EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biomarkers of liver diseases

Sukhbir Singh Tamber, Palak Bansal, Suraj Sharma, Rai Barinder Singh, Ramica Sharma

Molecular Biology Reports · 2023-09 · 50 (9) · 7815-7823

DOI: 10.1007/s11033-023-08666-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 24.07.2023. Verfasst von Sukhbir Singh Tamber und 4 weiteren Autor:innen. Beteiligte Einrichtung: University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali, Punjab, 140103, India. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease, Liver Neoplasms. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 105 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver is one of the pivotal organs in the human body and is fundamentally responsible for detoxification and metabolism. Various disorders such as non-alcoholic fatty liver disease, fibrosis, cirrhosis, hepatocellular carcinoma, and hepatitis are associated with improper functions of the liver. Hence, biomarkers are needed to determine the severity. Further, many liver enzymes, including the cascade of aspartate aminotransferase (AST)/serum glutamic oxaloacetic transaminase (SGOT), alanine aminotransferase (ALT)/serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT), and total bilirubin (TBIL), are conventional liver biomarkers. They are not, however, unique to the liver; hence, efforts are being made to identify the precise biomarkers for liver illness that can target liver diseases. HMGB1, cytokeratin 18 (K18), glutathione-S-transferase-α (GST-α), glutamate dehydrogenase (GLDH), malate dehydrogenase (MDH), and microRNAs (miRNA) are a few examples of developing biomarkers used to detect many liver diseases. Hence, the review has highlighted various novel biomarkers of the liver so that various pathophysiological pathways and treatments can be made easier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularNon-alcoholic Fatty Liver DiseaseLiver NeoplasmsHumansLiverLiver CirrhosisAlanine TransaminaseBiomarkersAspartate Aminotransferases

Stichwörter der Autor:innen

ALTBiomarkersFibrosisHMGB1LiverNAFLD

Substanzen

Alanine TransaminaseBiomarkersAspartate Aminotransferases

Autor:innen und Institutionen

  • University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali, Punjab, 140103, India.
  • University School of Pharmaceutical Sciences, Rayat-Bahra University, Mohali, Punjab, 140103, India. Ramica.17740@rayatbahrauniversity.edu.in.

Zitieren

APA

Tamber, S. S., Bansal, P., Sharma, S., Singh, R. B., & Sharma, R. (2023). Biomarkers of liver diseases. Molecular Biology Reports, 50(9), 7815-7823. https://doi.org/10.1007/s11033-023-08666-0

Vancouver

Tamber SS, Bansal P, Sharma S, Singh RB, Sharma R. Biomarkers of liver diseases. Molecular Biology Reports. 2023;50(9):7815-7823. doi:10.1007/s11033-023-08666-0

BibTeX
@article{Tamber2023,
  author = {Tamber, Sukhbir Singh and Bansal, Palak and Sharma, Suraj and Singh, Rai Barinder and Sharma, Ramica},
  title = {Biomarkers of liver diseases},
  journal = {Molecular Biology Reports},
  year = {2023},
  volume = {50},
  number = {9},
  pages = {7815--7823},
  doi = {10.1007/s11033-023-08666-0}
}
Kostenlos starten →